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Summary
 Background A survey of the literature on intraluminal brachytherapy reveals that even for a 
given tumour site, the dose prescribed varies considerably from one centre to 
another for multiple reasons: the treatment intent, the association with external 
beam therapy or not, the dose rate, the technique used and the point of dose 
speciﬁ cation. There is no common language in the literature as to how doses 
should be recorded and reported.
 Aim The purpose of this study was to dosimetrically evaluate various intraluminal 
brachytherapy applicators for the Gammamed high dose rate afterloading sys-
tem.
 Materials/Methods Dosimetric evaluation was carried out for 8mm, 10mm, 12mm and 14mm diam-
eter intraluminal applicators available with the Gammamed high dose rate after-
loading system. Treatment planning for these applicators was carried out with the 
Abacus treatment planning system for active source length and 8cm, 10cm and 
12cm. All evaluations were carried out for a prescription dose of 5Gy at the ref-
erence point of 1cm from the source axis. Reference volume length (RVL), treat-
ed volume (TV) and hyperdose sleeve radius (HSR) were noted down from the 
isodose plans. Iterative, geometric and equal times optimization routines were 
carried out for all evaluations with step size of 0.5cm.
 Results The isodose curves showed tapering pattern towards the distal and proximal re-
gions. The reference volume lengths were larger than active source lengths for 
8mm and 10mm diameter applicators. Reference volume lengths were smaller 
than active source lengths for 12mm and 14mm diameter applicators hyperdose 
sleeve radius decreases with increase in diameter of the applicator. For 14mm di-
ameter applicators, the hyperdose sleeve radius was smaller than the radius of the 
reference isodose. Iterative optimization routine gave a better average in terms 
of reference volume length for all four diameter applicators.
 Conclusions We evaluated the dosimetric parameters for various intraluminal applicators avail-
able with the Gammamed high dose rate remote afterloading system. The val-
ues of RVL and HSR were within acceptable limits for the four applicators con-
sidered in this study.
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BACKGROUND
There has been rapid growth in the use of in-
traluminal brachytherapy in recent years [1–4]. 
This technique is utilized in the treatment of tu-
mours of the oesophagus, lungs, trachea and 
the biliary tract. It is sometimes given with cura-
tive intent, but generally the vast majority of pa-
tients are not curable. Therefore the results are 
assessed within the context of palliative therapy, 
used alone or in association with other modalities 
such as laser treatment, surgery, external beam 
irradiation and chemotherapy. It can provide ef-
fective palliation quickly with minimal morbid-
ity at low cost.
A survey of the literature on intraluminal brachy-
therapy reveals that even for a given tumour site, 
the dose prescribed varies considerably from one 
centre to another for multiple reasons: the treat-
ment intent, the association with external beam 
therapy or not, the dose rate, the technique used 
and the point of dose speciﬁ cation. For instance 
the diameter of different applicators used to treat 
carcinoma of the oesophagus can vary from 0.5 
to 2.0cm and thus the dose delivered can vary by 
a factor of 4 according to the point of dose spec-
iﬁ cation. These important disparities result from 
the rapid dose fall off around a single source.
There is no common language in the literature 
as to how doses should be recorded and report-
ed. Most often when small diameter applicators 
are used, doses are prescribed and reported at 
a reference point 10mm from the source axis. 
Another practice of dose prescription and report-
ing which reﬂ ects more the individual situation 
in a patient is related to the applicator or to the 
oesophageal lumen. Usually a reference point at 
5mm from the applicator surface or at 5mm tis-
sue depth is chosen. Taking these different ref-
erence points, the reported reference doses and 
the dose gradients including the applicator and 
lumen surface doses vary signiﬁ cantly in partic-
ular when taking into account the different di-
ameters of the applicators used.
According to the recommendations of ICRU 58 
[2], the reference depth for reporting is speciﬁ ed 
in the central plane at 10mm from the source axis 
for small applicators. However, this recommenda-
tion is only related to the source and not to the in-
dividual application and the individual anatomy 
in the patient. The normal tissue of most concern 
with oesophageal brachytherapy, both in terms 
of acute and chronic side effects, is the normal 
oesophageal mucosa and underlying ﬁ bromus-
cular wall. The recommended active length doc-
umented by oesophagoscopy at the time of the 
planned brachytherapy is the visible mucosal tu-
mour with 1–2cm proximal and distal margin. The 
American Brachytherapy Society (ABS) guide-
lines [1] recommend prescribing the dose always 
at 10 mm from the mid-source or mid-dwell po-
sition without optimization. There is concern re-
garding the high dose to the normal oesophageal 
mucosa at the proximal and distal region of the 
active length if optimization programs are used. 
Furthermore there is great variation in the type of 
optimization used at different institutions.
AIM
The purpose of this study was to dosimetrically 
evaluate various intraluminal brachytherapy ap-
plicators for the Gammamed high dose rate af-
terloading system.
MATERIALS AND METHODS
Dosimetric evaluation was carried out for 8mm, 
10mm, 12mm and 14mm diameter intralumi-
nal applicators available with the Gammamed 
high dose rate afterloading system. Treatment 
planning for these applicators was carried out 
with the Abacus treatment planning system for 
active source length and 8cm, 10cm and 12cm. 
All evaluations were carried out for a prescrip-
tion dose of 5Gy at the reference point of 1cm 
from the source axis.
The following dosimetric entities were noted 
down as deﬁ ned.
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Reference volume length (RVL) – length of the 
90% isodose (4.5Gy) at the reference depth 
(Figure 1) [4].
Treated volume (TV) – volume encompassed by 
the reference isodose (5Gy) [3].
Hyperdose sleeve radius (HSR) – radius of the 
volume receiving a dose equal to or greater than 
twice the reference dose (Figure 2) [3,4].
Iterative, geometric and equal times optimization 
routines were carried out for all evaluations with 
step size of 0.5 cm.
RESULTS
Figure 3 shows the isodose plot for intraluminal 
applicators with radius 10mm for active source 
length and 10 cm with iterative optimization rou-
tine. Isodose curves for 5Gy, 4.5Gy and 1Gy are 
depicted in the ﬁ gure. The isodose curves showed 
a tapering pattern towards the distal and prox-
imal regions.
Dosimetric parameters for all four diameters are 
shown in Table 1. The reference volume lengths 
were larger than active source lengths for 8mm 
and 10mm diameter applicators. Reference vol-
ume lengths were smaller than active source 
length for 12mm and 14mm diameter applica-
tors. Hyperdose sleeve radius decreases with in-
crease in diameter of the applicator. For 14mm 
diameter applicators, the hyperdose sleeve radi-
us was smaller than the radius of the reference 
isodose. Iterative optimization routine gave a bet-
ter average in terms of reference volume length 
for all four diameter applicators.
DISCUSSION
We evaluated the dosimetric parameters for var-
ious intraluminal applicators available with the 
Gammamed high dose rate remote afterloading 
system. The values of RVL and HSR were within 
acceptable limits for the four applicators consid-
ered in this study. Such an evaluation gives an idea 
regarding dosimetric coverages for various treat-
ment planning parameters and assists in selec-
tion of these for a prospective clinical situation.
CONCLUSIONS
The length of the planning volume (PTL) is de-
termined taking into account tumour length, 
safety margins for subclinical extension and po-
sitional uncertainties. The length of the refer-
ence volume (RVL) is deﬁ ned as the length of 
the 90% isodose at the reference depth. The RVL 
should enclose the PTL as tightly as possible. The 
Figure 1. Defi nitions of dosimetric parameters.
Figure 2. Defi nition of tissue overdose volume.
Figure 3. Isodose distribution for 10cm active source length, 0.5cm 
step size, iterative optimization for 10mm diameter intraluminal 
applicator.
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Diameter (mm) Optimization routine
ASL (cm)
8 10 12
8
Iterative
RVL  8.7  10.82  12.88
TV  26.8  32.9  38.7
TSR  0.20  0.23  0.20
Geometric
RVL  8.12  10.24  12.16
TV  26.3  32.4  37.9
TSR  0.20  0.23  0.20
Equal Times
RVL  8.04  10.04  11.88
TV  26.2  32.0  37.0
TSR  0.20  0.23  0.17
10
Iterative
RVL  8.32  10.24  12.42
TV  26.8  32.9  38.7
TSR  0.1  0.1  0.1
Geometric
RVL  7.52  9.44  11.56
TV  26.3  32.4  37.9
TSR  0.1  0.1  0.1
Equal Times
RVL  7.26  9.2  10.7
TV  26.2  32.0  37.0
TSR  0.1  0.1  0.1
12
Iterative
RVL  7.46  9.76  11.82
TV  26.8  32.9  38.7
TSR  0.0  0.0  0.0
Geometric
RVL  6.32  8.38  11.02
TV  26.3  3.24  37.9
TSR  0.0  0.0  0.0
Equal Times
RVL  6.0  7.72  10.3
TV  26.2  32.0  37.0
TSR  0.0  0.0  0.0
14
Iterative
RVL  7.2  9.04  11.02
TV  26.8  32.9  38.70
TSR In In In
Geometric
RVL  6.6  8.64  10.24
TV  26.3  32.4  37.9
TSR In In In
Equal Times
RVL  6.12  7.84  9.64
TV  26.2  32.0  37.0
TSR In In In
Table 1. Values of dosimetric parameters for intraluminal applicators.
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hyperdose is important clinically because the tis-
sue volume covered by the hyperdose envelope 
correlates with treatment complication.
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